Deceased donor kidney transplantation (DDKT) confers a greater survival benefit to adult waitlist candidates on dialysis than those managed preemptively, investigators reported at the 2022 American Transplant Congress (ATC 2022) in Boston, Massachusetts.
The current US Kidney Allocation System (KAS) allows for DDKT candidates not yet on dialysis to accrue waiting time points by listing at a transplant center with a low estimated glomerular filtration rate. Read the full story in Renal & Urology News.